Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | TAS1R3 | Q7RTX0 | 8/20 | 0.52 |
| ▸ | TAS1R1 | Q7RTX1 | 8/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12932742 | 0.79 | KMT2A (0.64) | MAPK1PKMKMT2APOLBMEN1 | |
| SCHEMBL15925980 | 0.78 | PKM (0.72) | PKMKMT2APOLBTAS1R3TAS1R1 | |
| SCHEMBL702322 | 0.76 | TAS1R3 (0.81) | KMT2APOLBTAS1R3TAS1R1MEN1 | |
| SCHEMBL10975839 | 0.75 | KMT2A (0.50) | MAPK1KMT2APOLBTAS1R3TAS1R1 | |
| SCHEMBL10363494 | 0.74 | ALDH1A1 (0.62) | MAPK1PKMKMT2APOLBMEN1 | |
| SCHEMBL10363497 | 0.74 | ALDH1A1 (0.62) | MAPK1PKMKMT2APOLBMEN1 | |
| SCHEMBL5923939 | 0.74 | TAS1R3 (0.68) | POLBTAS1R3TAS1R1 | |
| SCHEMBL17935791 | 0.73 | SMN1; SMN2 (0.74) | MAPK1KMT2APOLBMEN1 | |
| SCHEMBL14350863 | 0.73 | KMT2A (0.59) | MAPK1KMT2APOLBMEN1 | |
| SCHEMBL702263 | 0.72 | TAS1R3 (0.60) | PKMKMT2ATAS1R3TAS1R1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012054526-A2 | CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES | ELCELYX THERAPEUTICS, INC. (US) | 2012-04-26 | — | — | WO | disclosed |